Skip to main content
Premium Trial:

Request an Annual Quote

Vela Diagnostics Receives EUA for Zika MDx

A previous version of this story incorrectly stated the Vela Zika test workflow uses Qiagen's Rotor-Gene Q platform. It uses the Applied Biosystems 7500 Fast Dx Real-Time PCR platform.

NEW YORK (GenomeWeb) – A Zika assay from Singapore-based molecular diagnostics firm Vela Diagnostics has received Emergency Use Authorization from the US Food and Drug Administration.

The Sentosa SA ZIKV RT-PCR Test processes 22 samples in three hours using Vela's Sentosa SX Virus Total Nucleic Acid Kit v2.0, and the Sentosa SX101 system for automated nucleic acid extraction and PCR set-up followed by thermal cycling on Applied Biosystems' 7500 Fast Dx Real-Time PCR platform.

For patients meeting US Centers for Disease Control and Prevention clinical or epidemiological criteria, the test is authorized to detect Zika RNA in serum, plasma, and urine collected alongside patient-matched serum or plasma.

Vela's Zika test was launched as a research-use-only product in January and received CE marking last month.

The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.